| Ioana Agache, MD, PhD | Sooyoung Lee, MD, PhD |
| Ignacio Ansotegui, MD, PhD | Bryan L. Martin, DO |
| James Baker, MD | J. Allen Meadows, MD |
| Jonathan Bernstein, MD | Mário Morais-Almeida, MD |
| Giorgio Walter Canonica, MD | Hideaki Morita, MD, PhD |
| Luis R. Caraballo, MD, PhD | Anna Nowak-Wegrzyn, MD |
| Yoon-Seok Chang, MD, PhD | José Antonio Ortega-Martell, MD |
| Adnan Custovic, DM, MD, PhD | Nikolaos G. Papadopoulos, MD, PhD |
| Stefano Del Giacco, MD | David Peden, MD, MS |
| Motohiro Ebisawa, MD, PhD | Philip Rouadi, MD |
| Philippe Eigenmann, MD | Robert P. Schleimer, PhD |
| David Fleischer, MD | Charles Schuler, MD |
| Alessandro Fiocchi, MD | James L. Sublett, MD |
| Pedro Giavina-Bianchi, MD, PhD | Shintaro Suzuki, MD, PhD |
| R. Maximiliano Gómez, MD, PhD | Paul Turner, PhD |
| Sandra González-Díaz, MD, PhD | Ronald van Ree, PhD |
| Matthew Greenhawt, MD, MBA, MSc | Carina Venter, PhD, RD |
| Elham Hossny, MD, PhD | Paul Williams, MD |
| Maria Jose Torres, MD, PhD | Gary W.K. Wong, MD |
| Luciana Kase Tanno, MD, PhD | Anahí Yañez, MD |
Due to a number of advances in the diagnosis and treatment of Food and Respiratory Allergies in recent years, there is a knowledge gap among treating physicians in these areas. The goal of this meeting is to bridge this knowledge gap by presenting lectures on proper diagnosis of and treatment options for Food and Respiratory allergies.
This symposium will be a focused program with tracks on food allergy and respiratory allergy. The sessions will benefit international researchers, clinicians, physicians and allied health professionals with interests in:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Allergy, Asthma & Immunology (AAAAI) and the World Allergy Organization (WAO). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum number of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following faculty have disclosed a relevant financial relationship:
Jonathan A. Bernstein, MD FAAAAI
Allakos, AstraZeneca, Sanofi-Regeneron (consultant); Amgen (research grant)
Yoon-Seok Chang, MD PhD AstraZeneca (research grant); GSK (advisory board); Organon, Sanofi (speaker); Jeil, Yuhan (honorarium)
Adnan Custovic, MD PhD FAAAAI
AstraZeneca: Speaker: ICS and GSK: Speaker: ICS
Stefano Del Giacco, MD
AstraZeneca, GSK, Novartis, Sanofi (advisory board); GSK, Sanofi (speaker)
Motohiro Ebisawa, MD PhD FAAAAI
ARS-Pharmaceuticals, Novartis, Sanofi (advisory board); Viatris (honorarium)
Philippe A. Eigenmann, MD FAAAAI DBV Technologies (advisory board)
Alessandro G. Fiocchi, MD Abbott, DBV Technologies, HiPP Organic, Novartis, Sanofi, Stallergenes Greer, Danone (advisory board)
David M. Fleischer, MD FAAAAI DBV Technologies (consultant)
Matthew J. Greenhawt, MD MBA MSc FAAAAI
Nutritcia (advisory board)
J. Allen Meadows, MD FAAAAI
Regeneron, Amgen, AstraZeneca, Sanofi, TEVA (speaker)
Anna H. Nowak-Wegrzyn, MD PhD FAAAAI
Nestle, Nutricia (speaker); UpToDate (royalty); Novartis (advisory board); Alladapt Immunotherapeutics (research grant)
Nikolaos G. Papadopoulos, MD
Abbott, Abbvie, Astra Zeneca, GSK, HAL, Medscape, Menarini/Faes Farma, Mylan, Novartis, Nutricia, OM Pharma, Regeneron/Sanofi (consultant)
Charles F. Schuler, IV, MD Gerber Foundation (research grant)
Paul J. Turner, FRCPCH PhD Aimmune, Allergenis, DBV Technologies (advisory board); Aquestive, Novartis, UK Food Standards Agency (consultant)
Ronald van Ree, PhD FAAAA Angany Inc., Citeq BV (consultant)
Carina Venter, PhD RD
Abbott, Danone, Nestle (speaker); Before Brands, Reckitt Benckiser (advisory board)
Speakers who disclosed a relevant financial relationship had their disclosure reviewed and mitigated.
No other speakers have disclosed a relevant financial relationship.
The following planning committee members have disclosed a relevant financial relationship:
Motohiro Ebisawa, MD PhD FAAAAI
ARS-Pharmaceuticals, Novartis, Sanofi (advisory board); Viatris (honorarium)
Planning Committee members who disclosed a relevant financial relationship had their disclosure reviewed and mitigated.
No other planning committee members have disclosed a financial relationship.
No staff member has disclosed a relevant financial relationship.
No commercial support was received for this activity.
Early Abstract Submission Opens
06 January 2023
Advanced Registration Opens
15 February 2023
Early Abstract Submission Closes
28 February 2023
Advanced Registration Ends
15 March 2023
Late-Breaking Abstracts Open
20 March 2023
Late-Breaking Abstracts Close
14 April 2023
On-site Registration Begins
17 May 2023
2023 WAO Symposium
18-20 May 2023
